Author(s): Srikanta Chandra, Tathagata Roy, Preeta Bose, Somsubhra Ghosh, Susanta Paul, Victor roychowdhury, Anannya Bose, Ankita Acharya

Email(s): troy@jisuniversity.ac.in

DOI: 10.52711/0974-360X.2022.00063   

Address: Srikanta Chandra1, Tathagata Roy2*, Preeta Bose3, Somsubhra Ghosh4, Susanta Paul5, Victor roychowdhury6, Anannya Bose7, Ankita Acharya8
1Assistant Professor, Jakir Hossain Institute of Pharmacy, Miapur, Murshidabad,742225.
2Assistant Professor, Department of Pharmaceutical Technology, JIS University, Kolkata-700109.
3Assistant Professor, Department of Pharmaceutical Technology, JIS University, Kolkata-700109.
4Assistant Professor, School or pharmacy, Techno India University, Salt Lake, Kolkata-700091, W.B.
5Assistant Professor, Department of Pharmaceutical Technology, JIS University, Kolkata-700109.
6Assistant Professor, Department of Pharmaceutical Technology, JIS University, Kolkata-700109.
7Assistant Professor, Department of Pharmaceutical Technology, JIS University, Kolkata-700109.
8Assistant Professor, Department of Pharmaceutical Technology, JIS University, Kolkata-700109.
*Corresponding Author

Published In:   Volume - 15,      Issue - 1,     Year - 2022


ABSTRACT:
Objective: Ulcerative colitis (UC) is a recurrent ulceroinflammatory disease that is mainly restricted to colonic mucosa with variable colonic architecture distortion. Different types of drugs are used for management of UC namely Salfasalazine, Balsalazide, Mesalamine etc. However, they are associated with different types of adverse effects such as nausea, vomiting, skin rash, headache. Hence, we narrowed in on Colocasia esculenta and its available in India, Bangladesh, Pakistan. In our present study the anticolitic effects Colocasia esculenta in treatment the TNBS induced model for UC in mice were examined. Methods: Male mice, 7 weeks of age, are selected. They are divided into various categories:Negative control groups treated with normal saline solution ,positive control group treated with TNBS5%, standard group treated with Balsalazide 4mg/kg & TNBS 5% , Test(1) group treated with Colocasia esculenta 100mg/kg, Test(2) group treated with Colocasia esculenta 150 mg/kg, Test(3) group treated with Colocasia esculenta 250 mg/kg then we were performed various parameters such as DAI, Oxidative damage assessment, MPO Assessment. Results: The results have been showed that Colocasia esculenta has significant activity against TNBS (5%) induced colitis when compared to the experimental control, with near normalization of colon architecture. Tissue oxidative stress was reduced with significant improvement in tissue levels of MDA &GSH. Furthermore, significant improvement in levels of myeloperoxidase (MPO) was observed. Conclusion: It is concluded that Colocasia esculenta(250mg/kg) has got potent activity against TNBS (5%) induced ulcerative colitis (UC) due to its anti-inflammatory& antioxidant properties.


Cite this article:
Srikanta Chandra, Tathagata Roy, Preeta Bose, Somsubhra Ghosh, Susanta Paul, Victor roychowdhury, Anannya Bose, Ankita Acharya. Protective Effect of Colocasia esculenta on TNBS Induced Ulcerative Colitis in Mice. Research Journal of Pharmacy and Technology. 2022; 15(1):385-8. doi: 10.52711/0974-360X.2022.00063

Cite(Electronic):
Srikanta Chandra, Tathagata Roy, Preeta Bose, Somsubhra Ghosh, Susanta Paul, Victor roychowdhury, Anannya Bose, Ankita Acharya. Protective Effect of Colocasia esculenta on TNBS Induced Ulcerative Colitis in Mice. Research Journal of Pharmacy and Technology. 2022; 15(1):385-8. doi: 10.52711/0974-360X.2022.00063   Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-1-63


REFERENCES:
1.    Verstockt Bram, Ferrante Marc, Vermeire Severine et al. New treatment option for inflammatory bowel diseas. The Japanese Society of Gastroenterology. 2018 Feb; 53(2) :585 -590
2.    Khor B, Garde A, Xavier. Ramnik. Genetics and pathogenesis of inflammatory bowel disease. International Journal of Science. 2011 June ;17(2): 307 -317
3.    Aldakeel K. Reem, Rehman Suriya, Almessiere A. Muirah, Khan A et al. Modern Treatment Strategy in Management of Ulcerative Colitis: A Systematic Review. Journal of Pharmaceutical Research .2018, 2(4):87-92
4.    Dianz Zaidi, E. Wine. Regulation of Nuclear Kappa –Light o-Enhancer of Activated B Cells in Inflammatory Bowel Diseases. World Journal of Gastroenterology.2018.17(2): 172-185
5.    Lichtenstein R. Gary, Edward V. Loftus Jr, Kim L. Isaacs, Miguel D. Regueiro et al. ACG Clinical Guideline:  Management of Crohn’s Disease in Adults. American Journal of Gastroenterology 2018; 113 :481 – 517
6.    Hyo Sun Lee, Soo –Kyung Park, Dong I1 Park; Novel treatments for inflammatory bowel disease; The Korean Journal of International Medicine .2018; 33(1):20-27
7.    Kathleen. A, Julie S.Jurenka. Inflammatory Bowel Disease Part I: Ulcerative Colitis – Pathophysiology and Conventional and Alternative Treatment Options; Altern Med Rev. 2003; 8(3): 247 -283
8.    Kanodia Lalit, Borgohain Mondita , Das Swranamoni. Effect of fruit extract of Fragaria vesca L. on experimentally induced inflammatory bowel disease in albino rats. Indian Journal of Pharmacology. 2011 Feb.43(1):18-21
9.    Patel MA, Patel PK, Patel MB; Aqueous Extract of Ficus bengalensis Linn. Bark for Inflammatory Bowel Disease. J Young Pharm.2010;2(2):130-136
10.    Somani S J, Badgujar L B, Sutariya B K, Saraf M N; Protective effect of Dillenia indica L. acetic acid induced colitis in mice. Indian Journal of Experimental Biology.2014;52(4): 876-881
11.    Salim S AL-Rejaie, Hatem M Abuohasish, Maher M Al – Enazi, et al. Protective effect of naringenin on acetic acid –induced ulcerative colitis in rats. World Journal of Gastroenterology.2013 14thSeptember; 19(34): 5633-5644
12.    MENG- Wan Yue, QING- Zhu You, BING Xia, JUN Luo. Treating TNBS –Induced colitis in rats with probiotics. Turk J Gastroenterol 2011; 22(5) :486-493
13.    FrangJiao –Yan, Lu Min, Zhao Yu –Ping et al. N- Methylcytisine Ameliorates Dextran – Sulfate –Sodium Induced Colitis in Mice by Inhibiting the Inflammatory Response. World Journal of Gastroenterology .2018 ,25th February 22 (5) :547-565
14.    Kim Youjin, G Alex Wu.  Chimedza Asha. Isothiocyanate –enriched Moringa seed extract alleviates ulcerative colitis symptoms in mice. World Journal of Gastro. 2017:3(2):  410-418
15.    Mohse. Minasyan, GhloamrezaAsghari, DianaTaheri, Mozhgan, Saeidi, SalarEsfahaniNasr. Anti –inflammatory effect of Moringa oleifera Lam. Seeds on acetic acid –induced acute colitis in rats. Avicenna Jour. of Phyto. 2014:4(2): 127-136

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available